Recent Headlines
Within Biotechnology
AnaSpec Introduces 58 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec has added fifty-eight (58) new antibody products to its growing collection. Anti-PTEN (pSer385) (polyclonal) - Cat# 29642-025, 25 µg Host: rabbit polyclonal; Species Reactivity: human; rat; mouse; Applications: IP; WB;... - March 16, 2008 - AnaSpec, EGT Group
Now Available on CD: Baxa Corporation Exhibitor’s Theatre, The Pros and Cons of Standardized Parenteral Nutrition, from ASHP Midyear Clinical Meeting
Colorado-based pharmacy products manufacturer, Baxa Corporation now has a CD available of the presentation, 'The Pros and Cons of Standardized Parenteral Nutrition” recorded live at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas. Presenter Gordon S. Sacks, PharmD, FCCP, BCNSP discusses the research related to parenteral nutrition compounding and the recommendations for best practice. - March 10, 2008 - Baxa Corporation
Device Promises to Heal the World's Sleep Problems
Those seeking better sleep without drugs look to technology that guarantees deeper, more recuperative sleep and enhanced daytime productivity. - March 09, 2008 - EarthPulse Tech, LLC
AnaSpec Introduces New SensoLyte™ Cathepsin D Activity Assay Kits
AnaSpec has introduced a new series of SensoLyte™ Cathepsin D Activity Assay Kits to address the issue of autofluorescence interference. - March 09, 2008 - AnaSpec, EGT Group
Trevigen Launches Anti-8-oxo-dG Monoclonal Antibody (Clone 2E2)
DNA damage caused by oxidative radicals is associated with aging, inflammation, carcinogenesis, Parkinson’s and Alzheimer’s diseases. When exposed to oxidative radicals, 8-hydroxy-2’-deoxyguanosine (8-oxo-dG) is formed and can serve as a sensitive indicator of physiological and... - March 06, 2008 - Trevigen, Inc.
AnaSpec Introduces Two Novel Amino Acids
AnaSpec has introduced two novel amino acids that offer additional tools and functionality for peptide chemists. - March 05, 2008 - AnaSpec, EGT Group
Otava Ltd. and Institute of Genetics and Molecular Medicine at University of Edinburgh Announce Research Collaboration
Otava Ltd., a leading Ukrainian company that specializes in drug discovery technologies, and Institute of Genetics and Molecular Medicine at University of Edinburgh, Cancer Research UK-p53 Signal Transduction Laboratories (UK), have announced plans for an integrated research project focused on a... - March 02, 2008 - OTAVA Chemicals Ltd.
Colorado Biosciences Get Boost, Advancing Major Economic Development Program
The Colorado House gave a big boost to a critical economic development project on Tuesday. A bill expanding Colorado’s much lauded Bioscience Discoveries Grant Program passed the House by an initial voice vote. House Bill 1001, sponsored by State Representative Jim Riesberg (D-Greeley), will make $26.5 million available in grants over the next five years. HB 1001 will provide as much as $150,000 per project to Colorado research institutions, accelerating the development of new technologies. - February 28, 2008 - Colorado BioScience Association
AnaSpec Introduces 9 New Antibody Products
AnaSpec added nine new antibody products to its growing collection. - February 28, 2008 - AnaSpec, EGT Group
AnaSpec Introduces 5 New Peptide Synthesis Reagents
AnaSpec added five (5) new peptide synthesis reagents to its combinatorial chemistry collection. - February 24, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Collection of Channel Blocker Peptides
AnaSpec has introduced its selection of channel blocker peptides. - February 21, 2008 - AnaSpec, EGT Group
Trevigen Launches High-Throughput PARP/Apoptosis Assays
Trevigen launches High-Throughput PARP/Apoptosis Assays ideal for measuring the activity of PARP in 96-well plates. Cell extracts can be obtained using their newly-developed, higher-throughput procedure before, during and after apoptosis induction. During apoptosis, PARP-1 which catalyzes the NAD... - February 20, 2008 - Trevigen, Inc.
Clinical Trials in Russia, 4th Quarter 2007
On February 18, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering various aspects... - February 20, 2008 - Synergy Research Group
AnaSpec Introduces New Suite of Fluorescently Labeled GST & 6xHis Tag Antibodies
AnaSpec has introduced a suite of fluorescently labeled GST and 6X-His antibodies. These antibodies are labeled with a selection of dyes, including AnaSpec’s proprietary HiLyte FluorTM and HiLytePlusTM dyes, which span the visible spectrum. This gives researchers a wide range of wavelength... - February 16, 2008 - AnaSpec, EGT Group
AnaSpec Introduces 46 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec added forty-six (46) new antibody products to its growing collection. Anti - GST Tag AMCA labeled - Cat# 29531-AMCA, 100 µg Host: mouse monoclonal; Application: IHC Anti - GST Tag Biotin labeled - Cat# 29531-BIOT, 100... - February 13, 2008 - AnaSpec, EGT Group
AnaSpec Introduces 21 New Anti-Tau Antibodies
AnaSpec has announced the release of 21 new anti-Tau antibodies. Complementing one of the world’s most comprehensive collections of beta-amyloid peptides, this new selection of anti-Tau antibodies demonstrates AnaSpec’s efforts to deliver new solutions for Alzheimer research. Tau is a... - February 11, 2008 - AnaSpec, EGT Group
Vascular BioSciences Awarded Phase 1 STTR Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Pulmonary Hypertension Research
Vascular BioSciences announced today it has received a STTR Phase 1 grant from the National Heart Lung Blood Institute of the National Institutes of Health in the amount of $165,745. The STTR award, “Targeting Pulmonary Hypertension with R-Ras,” will be performed in collaboration with... - February 10, 2008 - Vascular BioSciences, Inc
Baxa Corporation Launches New Web Site
Baxa announces the launch of its new corporate Web site with enhanced user features and technical content. The site provides a global platform for information exchange, product marketing, public relations, and sales and technical support for health-system pharmacists and nurses, as well as pharmaceutical industry representatives. - January 31, 2008 - Baxa Corporation
Colorado BioScience Association and Six Economic Development Groups Tout Colorado’s Strengths to the Medical Device Industry at MD&M West in Anaheim
Representatives from the Colorado BioScience Association (CBSA) and six of the state’s economic development entities are marketing Colorado as a desirable medical device manufacturing hub at the 24th annual Medical Device & Manufacturing (MD&M) West Expo. - January 31, 2008 - Colorado BioScience Association
AnaSpec Introduces 9 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat#... - January 27, 2008 - AnaSpec, EGT Group
Xcelience Expands Its Early Drug Development Capabilities
The Tampa-based CRO is first to acquire next generation Xcelodose. - January 26, 2008 - Xcelience, LLC
Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock® Set Saver
New Baxa eCampaign targets IV Nurses to introduce the PadLock Set Saver and honors nurses for their dedication to patients. The PadLock Set Saver device is designed to promote best practice for aseptic IV administration set storage, preventing contamination of the administration set when disconnected from the patient. The Set Saver also eliminates the use of IV administration set caps, which are a known choking hazard – especially in pediatric applications. - January 25, 2008 - Baxa Corporation
Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008
Anavex Life Sciences Corp. achieved significant development of its lead drug candidates and growth of its management and scientific teams during 2007. - January 24, 2008 - Anavex Life Sciences Corp.
AnaSpec Announces a Broad Selection of T-Cell Epitopes
AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, EGT Group
Anavex Strengthens Board of Directors
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.
Anavex 7-1037 Demonstrates Chemotherapeutic Potential Without Toxic Side Effects for the Treatment of Colorectal Cancer, Other Types of Solid Tumors
ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies. - January 16, 2008 - Anavex Life Sciences Corp.
Anavex Advances Drug Candidate for Treatment of Alzheimer's Disease
Results from animal model testing demonstrate ANAVEX 1-41 has significant neuroprotective and anti-amnesic benefits. - January 16, 2008 - Anavex Life Sciences Corp.
Trevigen Launches Cultrex BME PathClear
Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. - January 11, 2008 - Trevigen, Inc.
AnaSpec Introduces Ten New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group
Avoiding Steroids and Their Side Effects Should be Component in New Year’s Resolution of Athletes, Law Enforcement and Paramilitary
Unparalleled drug-free gains in strength, stamina and mental performance attainable through natural energetic alternative to steroids and banned performance enhancing drugs providing powerful ergogenic effects rivaling steroids, blood doping and other dangerous performance enhancement techniques while enhancing deep delta sleep, cardiovascular efficiency, cellular repair and mental acuity. - January 01, 2008 - EarthPulse Tech, LLC
"Clinical and Economical Considerations for Iv Push Drug Delivery" by Industry Expert Richard Rosenfeld is Now Accessible on Expert411.com for Media and Professional Use
The “Clinical and Economical Considerations For IV Push Drug Delivery” technical paper – authored by Industry Expert Richard Rosenfeld, RPh, MBA, for Baxa Corporation – is now accessible at Expert411.com for media and professional reference. The paper is an overview of the historical background for IV push and a model for implementation of a successful program. - December 27, 2007 - Baxa Corporation
AnaSpec Introduces Sixteen New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine... - December 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces First Colorimetric SensoLyte™ MMP Assay Kit
AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides
AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 10 New Catalog Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2... - December 15, 2007 - AnaSpec, EGT Group
The Holiday Gift for the Pet Who Has Everything
Pulsed magnetic fields provide strong anti-aging effects while enhancing physical performance in older pets where trauma, arthritis or age related joint deformity has resulted in chronic pain, loss of mobility and subsequent changes in behavior. - December 14, 2007 - EarthPulse Tech, LLC
AnaSpec Releases New Antibodies Brochure
With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented... - December 14, 2007 - AnaSpec, EGT Group
ValveXchange Wins The Third Annual Faegre & Benson Venture Showcase Award, Presented At BioWest 2007
ValveXchange has won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 conference in Denver. The announcement is made by Chris Shapard, Deputy Director of the Colorado BioScience Association (CBSA), who says the $10,000 Venture Showcase Award was again provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards luncheon at the Grand Hyatt Friday. - December 09, 2007 - Colorado BioScience Association
Gamma Medica-Ideas Announces the Sale of a Fully Digital Multi-Modality Pre-Clinical Imaging System to Louisiana State University Health Sciences Center
Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, has announced the sale of a fully digital multi-modality molecular imaging system for installation at Louisiana State University Health Sciences... - December 07, 2007 - Gamma Medica-Ideas
AnaSpec Introduces Eight New Catalog Peptides and One Unusual Amino Acid
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Collection of Bcl Peptides
AnaSpec introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. - December 06, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 17 New Anti-Tau Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) -... - December 06, 2007 - AnaSpec, EGT Group
Baxa Corporation Launches MedBoard™ Medication Tracking System
Baxa announces the introduction of MedBoard, the first wireless medication tracking system. MedBoard is featured at the Baxa booth (no. 2106) at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas, December 3 – 5, 2007. With its dynamic order monitoring, MedBoard reduces waste by identifying time-sensitive orders and ensuring on-time delivery. - December 03, 2007 - Baxa Corporation
Baxa Corporation Launches Repeater™ Pump II with P2™ Technology
Baxa announces the introduction of its next-generation Repeater Pump, the first no-calibration pharmacy pump, featuring unique P2 technology. The Repeater Pump II is featured at the Baxa booth (no. 2106) at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas, December 3 – 5, 2007. - December 03, 2007 - Baxa Corporation
Colorado BioScience Association Announces Winners of Its 2007 Awards Program, Honoring the Best of Colorado's Bioscience Industry
The Colorado BioScience Association (CBSA) has released winners of its 2007 Awards Program. Official presentation of the awards occurs Friday, December 7, 11:45 a.m. to 1:15 p.m., at the CBSA’s annual awards luncheon. Held in conjunction with the 2007 BioWest Conference at the Grand Hyatt Denver, registration information is available at the BioWest Conference website. - November 29, 2007 - Colorado BioScience Association
AnaSpec Celebrates the Holidays with Its Customers
AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, EGT Group
AnaSpec Introduces AnaTagTM Protein Labeling Kits with HiLytePlusTM
AnaSpec introduced a new series of AnaTagTM Labeling Kits now available with the revolutionary new HiLytePlus™ series of long-wavelength dyes. - November 29, 2007 - AnaSpec, EGT Group
Baxa to Sponsor Exhibitor’s Theatre: How to Get Your Administration to Buy What You Need: Building a Solid Business Plan 101 at ASHP
Colorado-based pharmacy products manufacturer, Baxa Corporation, is sponsoring a program at the annual American Society of Health-System Pharmacists’ Midyear Clinical Meeting in Las Vegas, December 3rd. The speaker will discuss key financial analyses and metrics and how to use them to build a compelling business plan. - November 27, 2007 - Baxa Corporation
Baxa to Sponsor Exhibitor’s Theatre: The Pros and Cons of Standardized Parenteral Nutrition at ASHP Midyear Clinical Meeting in Las Vegas
Colorado-based pharmacy products manufacturer, Baxa Corporation, is sponsoring a program at the annual American Society of Health-System Pharmacists’ Midyear Clinical Meeting in Las Vegas, December 3rd. The speaker will discuss parenteral nutrition safety issues and the differences between standardized formulations and a standardized process. - November 26, 2007 - Baxa Corporation
Gamma Medica-Ideas and Mayo Clinic Collaborate on New Breast Cancer Research Project
Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, has announced its collaboration with Mayo Clinic in an important, new breast cancer research project. The main goal of the project, funded by a... - November 23, 2007 - Gamma Medica-Ideas